Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutaredoxin 3 (GLRX3) is a multidomain oxidoreductase enzyme that functions primarily in the cytosol. It binds glutathione and catalyzes GSH-dependent reduction of protein disulfides. GLRX3 is critical for cytosolic iron–sulfur cluster assembly, working as a chaperone for [2Fe–2S] clusters and facilitating maturation of [4Fe–4S] proteins by transferring clusters to essential proteins involved in iron–sulfur assembly[1][3][5]. It regulates cellular redox homeostasis, protects cells from oxidative stress, inhibits apoptosis, and modulates cell survival, often localizing to the nucleus under oxidizing conditions to counteract environmental insults[3][4]. GLRX3 interacts with protein kinase C theta and is implicated in cardiac physiology by regulating hypertrophy and function[4]. Its expression and function have important roles in cancer, iron metabolism, and mitochondrial disorders[4][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutaredoxin 3 (GLRX3).